Medicorp Technologies India Limited is a public limited company engaged in the manufacture of Active Pharmaceutical Ingredients (API). The main objective of the
Company is to cater to innovator pharmaceutical companies and generic companies in the regulated markets such as USA, Canada and Europe. The Company has a state of-the-art cGMP facility at Hyderabad and has received US FDA approval for one of its products. The company has quality accreditations such as ISO 9001, ISO 14001 and approval from TGA (Australia). The company expects to be inspected by US FDA for at least two products every year from the year 2003 onwards. The company has in place, firm supply agreements for around ten products with some of the largest companies in USA, Canada and Europe for sole in the US and European markets within the next five years.